SAN DIEGO, November 05, 2024–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it entered into a definitive asset purchase agreement to sell its Rare…
November 05, 2024
November 05, 2024
Will BioXcel Therapeutics, Inc. (BTAI) Report Negative Q3 Earnings? What You Should Know
The market expects BioXcel Therapeutics, Inc. (BTAI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended…
SOUTH SAN FRANCISCO, Calif., November 05, 2024–(BUSINESS WIRE)–Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced that…
November 04, 2024
Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program
ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class,…
November 04, 2024
Talkspace Launches Campaign for Men’s Health Awareness Month Featuring Talkspace Members Opening up About the Importance of Mental Health
NEW YORK, November 04, 2024–(BUSINESS WIRE)–Today, Talkspace (NASDAQ: TALK), a leading online behavioral health care company, launched a new campaign for Men’s Health Awareness Month,…
November 01, 2024
Over 200% Stock Upside – Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
HC Wainwright initiated coverage on Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), a commercial-stage biopharmaceutical firm primarily focusing on neurological and neuropsychiatry disorders. HC Wainwright sees Vanda as…
November 01, 2024
Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024
SOUTH SAN FRANCISCO, Calif., November 01, 2024–(BUSINESS WIRE)–Vistagen (NASDAQ: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced it…
October 31, 2024
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Brainsway Ltd. Sponsored…
October 31, 2024
Reviva to Participate in the UBS Global Healthcare Conference
CUPERTINO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that…
US·Associated PressA mother intentionally went over Niagara Falls with her 2 children, police sayA 33-year-old mother climbed over a safety rail and intentionally went over…
October 31, 2024
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ: NRXP) will appear on the Emerging…
October 31, 2024
Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
Data of Blarcamesine confirm upstream SIGMAR1 activation Presented as Late Breaking Oral Communications at Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2024 Oral, once daily…